Judy Shon (@ShonJs) header
Judy Shon (@ShonJs) profile picture
Joined June 2013
Judy Shon retweeted
Thrilled to share our work on novo protein LYTAC(pLYTAC)/EndoTag in @nature! Using de novo protein design, we created endocytosis triggering binding proteins (EndoTags) to degrade extracellular targets and amplify receptor signaling. nature.com/articles/s41586-0…
7
117
7
522
68,757
Delivering and expressing a gene in cells is usually a messy (heterogeneous) process. The messiness interferes with research and applications such as gene therapy. In two new papers, we introduce a toolbox of synthetic miRNA-based control circuits that enable more precise, gene dosage-invariant gene expression, and show how they improve a mouse model of Rett syndrome gene therapy: biorxiv.org/content/10.1101/… ,led by @RongrongDu123 and @MichaelJAFlynn biorxiv.org/content/10.1101/… , led by @MichaelJAFlynn and Acacia Mayfield, in collaboration with Viviana Gradinaru.
8
199
16
844
127,904
Our paper on lineage motifs is now online at @Dev_Cell 😀 We hope that this approach will be widely useful for anyone interested in analyzing tree-type datasets!
4
15
1
49
13,678
Out now on @biorxivpreprint! In my first project in the @ElowitzLab, we explore how competitive, "many-to-many" dimerization allows complex, multi-input, and cell-type-specific biochemical computations🧵↓ doi.org/10.1101/2023.10.30.5…
5
51
5
179
58,785
New preprint: Networks of dimerizing proteins turn out to be powerful computational systems. In tweetorial form here by @JacobParresAu, who led this work with @BenEmert, Matt Levine, and Andrew Stuart.
Out now on @biorxivpreprint! In my first project in the @ElowitzLab, we explore how competitive, "many-to-many" dimerization allows complex, multi-input, and cell-type-specific biochemical computations🧵↓ doi.org/10.1101/2023.10.30.5…
24
107
28,011
Judy Shon retweeted
Excited to share my PhD work, out now in @ScienceMagazine ! What governs successful lysosomal degradation of membrane proteins mediated by extracellular degraders? Can we improve degradation efficacy? science.org/doi/10.1126/scie…🧵(1/n)
13
77
7
556
142,205
Excited to share this work from @tineisadora! Precise control over protein subcellular localization could have massive implications for gain-of-function therapeutic strategies. We showcase targeted relocalization activating molecules (TRAMs) for rewiring interactomes. (1/n)
Targeted Protein Relocalization via Protein Transport Coupling biorxiv.org/cgi/content/shor… #bioRxiv
4
42
10
157
86,475
🎉🎉Super excited to announce that our manuscript on T cell immunoglobulin and mucin-domain containing (TIM) proteins was published in @NatureComms! We used glycoproteomics to drive MD simulations and understand how #glycotime affects structure/function: doi.org/10.1038/s41467-023-4…
13
41
5
232
57,236
Want to sequence RNA from cells without killing them or deliver RNA programs from cell to cell? Today in Cell, we present RNA exporters, which package and secrete cellular RNA, for non-destructively monitoring cell dynamics by sequencing and delivering RNA authors.elsevier.com/sd/arti…
28
262
37
1,041
178,157
RNA is informant and agent. Controlled RNA export from cells could enable cell-cell delivery of functional and non-destructive tracking of cell dynamics. Our new paper, led by brilliant @FelixHorns, engineers RNA export for both capabilities: authors.elsevier.com/sd/arti…
3
103
7
411
61,667
🚨🚨New #mucinome preprint! We used glycoproteomics and MD simulations to understand TIM-3/4 stx/fxn! Buckle up for this wild ride that involved collaborative #glycotime efforts from so many, esp @joann_chong @A_Steigmeyer @keira_erol @mia_rosenfeld 🧵👇biorxiv.org/content/10.1101/…
11
35
9
166
84,656
To map cellular sources of the dynamic circulating proteome, we (@WeiWei_Stanford, @LyuXuchao, @longlabstanford, @CarolynBertozzi, and more) expanded our cell-type selective secretome strategy to generate a 21-cell type, 10-tissue map of exercise-regulated secretomes in mice.
Organism-wide secretome mapping uncovers pathways of tissue crosstalk in exercise biorxiv.org/cgi/content/shor… #bioRxiv
3
18
3
80
Excited to share our new @biorxivpreprint! We developed antibody-lectin (AbLec) chimeras as a modular molecular architecture to target sugars, or glycans, for cancer immunotherapy. 1/n tinyurl.com/5yw69eeu #glycotime @CarolynBertozzi @Stanford_ChEMH @StanfordUChem @HHMINEWS
8
68
5
373
Congrats @CarolynBertozzi!!! 🥳🎉🍾
BREAKING NEWS: The Royal Swedish Academy of Sciences has decided to award the 2022 #NobelPrize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.”
27
BREAKING NEWS: The Royal Swedish Academy of Sciences has decided to award the 2022 #NobelPrize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.”
332
9,497
2,285
25,247
Bertozzians reunite at #mucin2022 ⁦@AngelKuo9⁩ ⁦@ShonJs⁩ ⁦@lindsaychembio⁩ ⁦@CarolynBertozzi⁩
2
31
We hope this can be a useful platform for defining endogenous mucin-domain glycoproteins in complex biological systems. Challenges certainly still remain, but this can be one option to make mucin-centric #glycotime questions more approachable.
This Post is from an account that no longer exists. Learn more
1
4
53
THE #MUCINOME HAS FINALLY BEEN REVEALED! Huge thanks to co-first author @riley_nm1, co-authors @ShonJS, @KayvonPedram, Venkat and Oliver, and of course our fearless #glycotime leader @CarolynBertozzi. Out now in @NatComm: rdcu.be/cP1Qu
14
67
4
370